StockData
Natera, Inc. logo

Natera, Inc.

NTRANasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 10/30234% above fair value
$378.92−35.38 (-8.54%)

Close on Nov 2, 2026Market cap $54.62BP/E –Yield –

Natera Contract Liability Roll-Forward: Revenue Recognized by Quarter

Contract Liability Roll-Forward: Revenue Recognized from Beginning Balance ($M) ($M)

Natera Contract Liability Roll-Forward: Revenue Recognized: -$11.8M in Q2 2026, up 114.8% from a year earlier.

Latest, Q2 2026
-11.8
Period ended Jun 30, 2026
Change on a year earlier
+114.8%
-5.48 in Q2 2025
History
32 quarters
Since Q3 2018
Sources
28
Documents cited below

Where the Q2 2026 figure comes from

Calculated from reported figures: quarter = year-to-date − previous year-to-date (cash flow statement)

Source: Form 10-Q (2026-08-07) ↗

Reported in Form 10-K/10-Q Note — Contract Liabilities Roll-Forward (XBRL).

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedContract Liability Roll-Forward: Revenue Recognized from Beginning Balance ($M) ($M)Year on yearSource
Q2 2026Jun 30, 2026-11.8+114.8%Form 10-Q (2026-08-07) ↗
Q1 2026Mar 31, 2026-11.3+20.0%Form 10-Q (2026-05-08) ↗
Q4 2025Dec 31, 2025-2.80+76.1%Form 10-K (2026-02-27) ↗
Q3 2025Sep 30, 2025-1.50-38.8%Form 10-Q (2025-11-07) ↗
Q2 2025Jun 30, 2025-5.48+110.8%Form 10-Q (2026-08-07) ↗
Q1 2025Mar 31, 2025-9.42+33.6%Form 10-Q (2026-05-08) ↗
Q4 2024Dec 31, 2024-1.59+67.4%Form 10-K (2026-02-27) ↗
Q3 2024Sep 30, 2024-2.45+17.2%Form 10-Q (2025-11-07) ↗
Q2 2024Jun 30, 2024-2.60-26.3%Form 10-Q (2025-08-08) ↗
Q1 2024Mar 31, 2024-7.05+76.7%Form 10-Q (2025-05-09) ↗
Q4 2023Dec 31, 2023-0.95+5.6%Form 10-K (2025-02-28) ↗
Q3 2023Sep 30, 2023-2.09-1.4%Form 10-Q (2024-11-12) ↗
Q2 2023Jun 30, 2023-3.53+88.8%Form 10-Q (2024-08-09) ↗
Q1 2023Mar 31, 2023-3.99+2.6%Form 10-Q (2024-05-10) ↗
Q4 2022Dec 31, 2022-0.90-81.7%Form 10-K (2024-02-29) ↗
Q3 2022Sep 30, 2022-2.12+5.0%Form 10-Q (2023-11-09) ↗

Cite this data

StockData. (2026). Natera Contract Liability Roll-Forward: Revenue Recognized ($M), quarterly Q3 2018–Q2 2026 [Data set]. Compiled from Natera SEC filings and investor materials. https://stockdatahq.com/stocks/ntra/kpis/contract-liab-rev-from-beg-balance

See every metric in the Natera KPI table. Data updated Nov 2, 2026.